Shriners Hospitals for Children study reveals new link to arthritis

January 08, 2021

(St. Louis) - A new study by investigators at the Shriners Hospital for Children -- St. Louis suggests the damaging effects of obesity are not due to body weight but rather come from something much smaller - biochemical signals released by fat cells.

The study focuses on the link between overweight or obesity and the development of osteoarthritis, a painful disease of the joints. The investigation was led by Dr. Farshid Guilak, director of the St. Louis Shriners Hospital Research Center.

"We've shown here that it's not overloading of the joints that is responsible for osteoarthritis, but, more likely, a factor given off by fat cells that makes cartilage susceptible to degeneration," said Guilak, who also serves as the Mildred B. Simon Professor of Orthopaedic Surgery at Washington University, a partner of the St. Louis Shriners Hospital.

While historically regarded as an unavoidable part of aging, osteoarthritis is now appearing more commonly in children. This is due in part to widespread increases in childhood obesity, coupled with injuries that commonly occur in adolescents, such as knee ligament tears. Little scientific research had been done in the past on the connection between obesity and osteoarthritis because, Guilak said, it was simply dismissed as byproduct of overloading the joints with increased body weight. But the new study by investigators at the St. Louis Shriners Hospital and the Washington University School of Medicine shows that weight gain alone isn't the cause.


The researchers used a unique type of mouse that has no fat cells anywhere in their bodies. Even when they were fed an unhealthy, extremely high-fat diet, these mice did not develop osteoarthritis in any of their joints. The researchers were surprised to find that even with a knee injury that normally causes rapid degeneration of the cartilage, fat-free mice were protected from getting osteoarthritis.

Then, the researchers implanted a tiny piece of fat under the skin of these mice, so small it had no effect on their body weight. The mice became susceptible to osteoarthritis, even though there was no weight gain. This showed researchers that fat outside the knee joint plays a critical role in cartilage health.

The study was published in the journal Proceedings of the National Academy of Sciences. It was designed and executed by the lead author Dr. Kelsey Collins, a postdoctoral fellow in Guilak's laboratory.

"This study demonstrates that factors outside of the knee joint can affect cartilage health, which opens the door for a wide range of new osteoarthritis treatment targets we can investigate," Collins said. "Once we identify the factors given off by fat cells that are responsible for these effects on the joint, we hope to develop new drugs to target them."

In the meantime, Guilak, who also co-directs the Washington University Center for Regenerative Medicine and is a professor of biomedical engineering and of developmental biology, said that a healthy diet and weight loss are the first lines of prevention for osteoarthritis.

"Something like this could take years to develop, but we're excited about its prospects for reducing joint damage, as well as many of the other unhealthy effects of obesity," Collins said.
Collins, K.H., Lenz, K.L., Pollitt, E.N., Ferguson, D., Hutson, I., Springer, L.E., Oestreich, A.K., Tang, R., Choi, Y.R., Meyer, G.A., Teitelbaum, S.L., Pham, C.T.N., Harris, C.A., and Guilak, F. Adipose tissue is a critical regulator of osteoarthritis, Proceedings of the National Academy of Sciences USA, published online December xxx, 2020.

This work was supported by the Shriners' Hospitals for Children, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute on Aging and the Office of the Director of the National Institutes of Health (NIH). Grant numbers AR074992, DK108742, DK007120, AR50245, AG15768, AG46927, AR076820, AR073752, and OD10707. Additional funding was provided by the Arthritis Foundation and the Nancy Taylor Foundation for Chronic Diseases.

Shriners Hospitals for Children strives to transform children's lives by providing exceptional health care through high-quality, innovative research in a patient and family-centered environment. We are committed to the pursuit of seminal, cutting-edge discoveries that result in new knowledge and improve the therapeutic treatment, quality of care and provided outcomes to our patients and their families. Today's research is tomorrow's patient care.

Corporate Headquarters | 800-237-5055 | 2900 Rocky Point Dr., Tampa, FL 33607

Shriners Hospitals for Children is a 501(c)(3) tax-exempt organization - #85-8012616616C-6
Federal identification number EIN 36-2193608

Shriners Hospitals for Children

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to